A detailed history of Sax Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sax Wealth Advisors, LLC holds 355 shares of LLY stock, worth $281,919. This represents 0.03% of its overall portfolio holdings.

Number of Shares
355
Previous 361 1.66%
Holding current value
$281,919
Previous $326,000 3.68%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $4,632 - $5,760
-6 Reduced 1.66%
355 $314,000
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $261,678 - $328,163
361 New
361 $326,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $191,694 - $225,982
365 New
365 $212,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sax Wealth Advisors, LLC Portfolio

Follow Sax Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sax Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sax Wealth Advisors, LLC with notifications on news.